Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma

23 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to HER2/EGFR in Cancer Research
Share to Melanoma and MAPK Pathways

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 20425073
DOI: 10.1007/s11912-010-0095-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant MelanomaPMID 20425073Read ↗

A Progressive Review of V600E-B-RAF-Dependent Melanoma and Drugs Inhibiting It.Semantic proximity Read ↗

Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma.Semantic proximity Read ↗

The genesis of Zelboraf: targeting mutant B-Raf in melanoma.Semantic proximity Read ↗

Emerging targeted therapies for melanoma.Semantic proximity Read ↗

BRAF as a potential therapeutic target in melanoma and other malignancies.Semantic proximity Read ↗

Targeted therapy in BRAF‑mutant melanoma: Advances and challenges (Review).Semantic proximity Read ↗

Targeted Therapy Innovations for Melanoma.Semantic proximity Read ↗

Targeting RAS/RAF/MEK/ERK signaling in metastatic melanomaSemantic proximity Read ↗

B-RAF: A contributor to the melanoma phenotype.Semantic proximity Read ↗

Evolution of Molecular Targets in Melanoma Treatment.Semantic proximity Read ↗

Immunotherapy in Melanoma: A Dynamic Frontier in Cancer Treatment : Author List.Semantic proximity Read ↗

Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.